Comparison of ceftriaxone, amikacin, and ciprofloxacin in treatment of experimental Yersinia enterocolitica O9 infection in mice

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 11, 1998, Pages 3009-3011

  Jiménez Valera, Maria ^a   Gonzalez Torres, Concepción ^a   Moreno, Encarnación ^a   Ruiz Bravo, Alfonso ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFTRIAXONE; CIPROFLOXACIN;

ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CONTROLLED STUDY; DIARRHEA; EXPERIMENTAL INFECTION; FEMALE; GASTROINTESTINAL INFECTION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; YERSINIA ENTEROCOLITICA;

EID: 0344835812     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.11.3009     Document Type: Article

References (18)

1. Ambrose, N. S., M. Johnson, B. W. Burdon, and M. R. Keighley. 1985. The influence of single dose intravenous antibiotics on faecal flora and emergence of Clostridium difficile. J. Antimicrob. Chemother. 15:319-326.
2. Bakour, R., G. Balligand, Y. Laroche, G. Cornelis, and G. Wauters. 1985. A simple adult-mouse test for tissue invasiveness in Yersinia enterocolitica strains of low experimental virulence. J. Med. Microbiol. 19:237-246.
3. Bergan, T., C. Delin, S. Johansen, I. M. Kolstad, C. E. Nord, and S. B. Thorsteinsson. 1986. Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora. Antimicrob. Agents Chemother. 29:298-302.
4. Bottone, E. J. 1997. Yersinia enterocolitica: the charisma continues. Clin. Microbiol. Rev. 10:257-276.
5. Brumfitt, W., I. Franklin, D. Grady, J. M. T. Hamilton-Miller, and A. Iliffe. 1984. Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers. Antimicrob. Agents Chemother. 26:757-761.
6. Cover, T. L., and R. C. Aber. 1989. Yersinia enterocolitica. N. Engl. J. Med. 321:16-24.9.
7. Gemski, P., J. R. Lazere, and T. Casey. 1980. Plasmid associated with pathogenicity and calcium dependency of Yersinia enterocolitica. Infect. Immun. 27:682-685.
8. Gismondo, M. R., L. Drago, A. Lombardi, C. Fassina, and M. Cesana. 1995. Impact of rufloxacin and ciprofloxacin on the intestinal microflora in a germ-free mice model. Chemotherapy 41:281-288.
9. Jimenez-Valera, M., A. Sampedro, E. Moreno, and A. Ruiz-Bravo. 1995. Modification of immune response in mice by ciprofloxacin. Antimicrob. Agents Chemother. 39:150-154.
10. Kwaga, J., and J. O. Iversen. 1990. In vitro antimicrobial susceptibilities of Yersinia enterocolitica and related species isolated from slaughtered pigs and pork products. Antimicrob. Agents Chemother. 34:2423-2425.
11. Mazigh, D., J. M. Alonso, and H. H. Mollaret. 1983. Simple method for demonstration of differential colony morphology of plasmid-associated virulent clones of Yersinia enterocolitica. J. Clin. Microbiol. 17:555-557.
12. Morris, J. G., V. Prado, C. Ferreccio, R. M. Robins-Browne, A. M. Bordun, M. Cayazzo, B. A. Kay, and M. M. Levine. 1991. Yersinia enterocolitica isolated from two cohorts of young children in Santiago, Chile: incidence of and lack of correlation between illness and proposed virulence factors. J. Clin. Microbiol. 29:2784-2788.
13. Ruiz-Bravo, A., M. Jimenez-Valera, G. Alvarez de Cienfuegos, C. Ruiz, K. Kouwatli, and A. Ramos-Cormenzana. 1985. Immunomodulation in mice by experimental infection with Yersinia enterocolitica. Microbiol. Immunol. 29: 1089-1097.
14. Ruiz-Bravo, A., M. Jimenez-Valera, and S. M. Roman. 1996. Nonspecific modification of cellular immunity by Yersinia enterocolitica. Immunol. Lett. 49:57-61.
15. Salyers, A. A., and D. D. Whitt. 1994. Bacterial pathogenesis: a molecular approach. American Society for Microbiology, Washington, D.C.
16. Sanford, J. P. 1992. Guide to antimicrobial therapy. Antimicrobial Therapy, Inc., Dallas, Tex.
17. Smith, H. 1988. The state and future of studies on bacterial pathogenicity, p. 365-382. In J. A. Roth (ed.), Virulence mechanisms of bacterial pathogens. American Society for Microbiology, Washington, D.C.
18. Woods, G. L., and J. A. Washington. 1995. Antibacterial susceptibility tests: dilution and disk diffusion methods, p. 1327-1341. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.